Japan listing sets stage for edoxaban, vaniprevir launches
This article was originally published in Scrip
Executive Summary
Japan has granted reimbursement prices to a batch of new drugs, including a new therapy for hepatitis C, a novel anticoagulant and a new insomnia treatment.